Every company is talking about how AI will enhance efficiency. But here’s the question almost nobody is asking: Are you ...
India’s manufacturing sector contributes 17 per cent of GDP and employs over 27 million people. A new wave of AI deployment ...
Ferrari’s new sportscar, the Luce (pronounced Loo-che), raises some interesting questions about the future of hi-tech, high-cost supercars in the electric era. The Italian sportscar maker’s first move ...
NEW YORK CITY, NY / ACCESS Newswire / June 9, 2026 / Since our founding a bit over 30 years ago, Horizon Kinetics’ mission remains unchanged: the disciplined pursuit of long-term capital compounding ...
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
As Dr. Bing Xia emphasized, hit identification is highly target-dependent and is not best approached as a fixed route. Strategy selection should begin with the target context, including biological ...
Share on Pinterest The FDA puts forward a move to exclude GLP-1 drugs from the bulk compounding list. Image credit: VICTOR TORRES/Stocksy On April 30, 2026, the U.S. FDA announced it is considering ...
Windows and Android platforms have been trying to catch up to Apple’s ecosystem. And honestly, in some areas, they have succeeded. But replicating a feature here and there is very different from ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
INDIANAPOLIS — The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight loss drugs, GLP-1s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results